Monitoring of r-Hirudin Anticoagulation during Cardiopulmonary Bypass – Assessment of the Whole Blood Ecarin Clotting Time

Bernd Pötzsch, Katharina Madlener, Christoph Seelig, +3

Thrombosis and Haemostasis

MONITORING OF RECOMBINANT HIRUDIN: ASSESSMENT OF A PLASMA-BASED ECARIN CLOTTING TIME ASSAY

Bernd Pötzsch, Simone Hund, Katharina Madlener, +2

Thrombosis Research

ThrombosisMedicineBioanalysisHematologyLaboratory Medicine +8

Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited

Erwin Stolz, José M. Valdueza, Mathias Grebe, +8

Journal of Neurology

Cerebral Venous ThrombosisNeurovascular DiseaseAnemiaThrombosisVenous Thrombosis +15

Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia

Marc Schindewolf, Julia Steindl, Jan Beyer‐Westendorf, +12

Journal of the American College of Cardiology

ThrombopoiesisThrombosisFondaparinux Off-labelBlood PlateletHematology +7

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) – findings from the GerHIT multi-centre registry study

Marc Schindewolf, Julia Steindl, Jan Beyer‐Westendorf, +12

Thrombosis Research

ThrombosisBlood PlateletHematologyFrequent Off-label UseNeurology +4

A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery

Rainer Bader, N. Bleese, Céline Löwer, +4

European Journal of Cardio-Thoracic Surgery

Heart FailureCardiac AnaesthesiaSurgeryThrombosisVenous Thrombosis +18

Gene Expression Analysis in Platelets from a Single Donor: Evaluation of a PCR-Based Amplification Technique

Jutta M. Rox, Peter Bugert, Jens Müller, +5

Clinical Chemistry

Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass

Michael Weber, Matthias Rau, Katharina Madlener, +4

Clinical Biochemistry

Cardiac MuscleHeart FailureCardiovascular DiseaseDiagnostic UtilityCardiac Markers +12

Red blood cells treated with the amustaline (S‐303) pathogen reduction system: a transfusion study in cardiac surgery

V. Brixner, Katharina Madlener, Markus Müller, +16

Transfusion

Is Heparin Treatment the Optimal Management for Cerebral Venous Thrombosis?

Carina Röttger, Katharina Madlener, Matthias Heil, +6

Stroke